These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6001925)

  • 21. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A rare case of factor VIII-inhibitor formation].
    Eckstein A; Voss B; Taubert W; Scheja J
    Dtsch Zahnarztl Z; 1986 Apr; 41(4):398-9. PubMed ID: 3091357
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibitors in mild/moderate haemophilia A: an update.
    Franchini M; Salvagno GL; Lippi G
    Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of factor VIIICAg-positive severe hemophilia A with factor VIII inhibitor].
    Shima M; Imai S; Tsubura Y; Yoshioka A; Tsukada S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):843-8. PubMed ID: 3929526
    [No Abstract]   [Full Text] [Related]  

  • 25. Mutations in severe hemophilia A: distribution within the factor VIII gene, origin and influence on inhibitor development.
    Oldenburg J; Grimm T; Becker J; Olek K; Brackmann HH; Schwaab R
    Beitr Infusionsther Transfusionsmed; 1997; 34():224-30. PubMed ID: 9356677
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biochemical aspects of hemophilia].
    Rutberg RA
    Lab Delo; 1977; (3):185-7. PubMed ID: 67277
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: Continuous thrombin irrigation for abscessed hematoma in hemophiliac with factor VIII inhibitor.
    Wimer BM
    Thromb Diath Haemorrh; 1975 Dec; 34(3):855-8. PubMed ID: 1209548
    [No Abstract]   [Full Text] [Related]  

  • 28. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factor VIII inhibitors in the French hemophiliac population (proceedings)].
    Sultan Y; Maisonneuve P
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(3):671-3. PubMed ID: 600788
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: A more uniform measurement of factor VIII inhibitors.
    Kasper CK; Aledort L; Aronson D; Counts R; Edson JR; van Eys J; Fratantoni J; Green D; Hampton J; Hilgartner M; Levine P; Lazerson J; McMillan C; Penner J; Shapiro S; Shulman NR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):612. PubMed ID: 1198543
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemophilia A complicated by the presence of a circulating anticoagulant].
    Zawilska K; Owczarek L; Furmaniuk J
    Acta Haematol Pol; 1973; 4(3):265-8. PubMed ID: 4754133
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired circulating anticoagulant in classical hemophilia: treatment with prothrombin concentrate.
    Rosen R; Mikel T; Corrigan JJ
    Ariz Med; 1977 May; 34(5):340-2. PubMed ID: 883905
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating anticoagulant in patients with hemophilia A.
    Uszyński L; Lopaciuk S
    Pol Med J; 1969; 8(4):862-9. PubMed ID: 4105591
    [No Abstract]   [Full Text] [Related]  

  • 35. [Autocorrection of coagulation time in Hemophilia A].
    Schneer JH; Chipail A; Mănăila T
    Rev Med Chir Soc Med Nat Iasi; 1975; 79(2):211-4. PubMed ID: 1166156
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suppression of an anti-factor VIII inhibitor using the simultaneous administration of prednisone and factor VIII].
    Díaz Cremades JM
    Sangre (Barc); 1985; 30(1):59-60. PubMed ID: 3923634
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates.
    Tagariello G; Zanotto D; Radossi P; Sartori R; Belvini D; Salviato R
    Am J Hematol; 2007 Jun; 82(6):460-2. PubMed ID: 17211843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
    Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required.
    Calvez T; Laurian Y
    Br J Haematol; 2006 Mar; 132(6):798-800; author reply 800-1. PubMed ID: 16487187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.